Evidence map›Paper›PMID 36718820›Full record

ArticleHistology and histopathology2023

circRNA-SMO upregulates CEP85 to promote proliferation and migration of glioblastoma via sponging miR-326.

Bin Wu, Liang Xia, Shuyuan Zhang, Kai Jin, Liwen Li, Caixing Sun, Ting Xia, Gao Chen

Abstract read
PubMed Publisher
In one paragraph

Article in Histology and histopathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. The Glioblastoma CircularRNAome.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Bin WuDepartment of Neurosurgery, The Second Affiliated Hospital of Medical College of Zhejiang University, Hangzhou, Zhejiang Province, China.
Liang XiaDepartment of Neurosurgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang Province, China.
Shuyuan ZhangDepartment of Neurosurgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang Province, China.
Kai JinDepartment of Neurosurgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang Province, China.
Liwen LiDepartment of Neurosurgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang Province, China.
Caixing SunDepartment of Neurosurgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang Province, China.
Ting XiaInstitute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang Province, China.
Gao ChenDepartment of Neurosurgery, The Second Affiliated Hospital of Medical College of Zhejiang University, Hangzhou, Zhejiang Province, China. d-chengao@zju.edu.cn.
Zhejiang Cancer Hospital · CN

Funding

Zhejiang Medical Science and Technology Project 2018KY292Zhejiang Medical Science and Technology Project 2021KY092
6 · The paper itself

Abstract

Circular RNAs (circRNAs) play an important role in cancer development by sponging microRNAs (miRNAs) to regulate the signaling axis. However, more comprehensive mechanisms of circRNAs in glioblastoma need to be elucidated. RT-qPCR was used to detect the expression levels of circRNA-SMO and miR-326. Dual-luciferase reporter assays were conducted to verify the interaction among circRNA-SMO, miR-326, and CEP85. Flow cytometric analysis was performed to detect apoptosis. Western blotting was used to determine the protein levels of the different molecules. Animal xenograft experiments were performed to evaluate the role of circRNA-SMO in vivo. CircRNA-SMO was upregulated in glioblastoma tissues and glioblastoma cells. CircRNA-SMO downregulation inhibited the viability and colony-forming ability of the glioblastoma cells. In addition, miR-326 was downregulated in glioblastoma cells, which was verified to sponge circRNA-SMO and interact with CEP85. Moreover, circRNA-SMO inhibition induced the elevation of miR-326 and apoptosis, accompanied by a decrease in CEP85. CircRNA-SMO knockdown-mediated tumor inhibition was prevented by an miR-326 inhibitor. Furthermore, circRNA-SMO inhibition inhibited tumor growth in vivo, accompanied by an increase in miR-326 and a decline in CEP85 in tumor tissues. Conclusions. CircRNA-SMO sponges miR-326 to promote glioblastoma proliferation and migration by upregulating CEP85 expression. This study clarified the role of circRNA-SMO in the development of glioblastoma, providing novel insights for its treatment.

Indexed as

GlioblastomaMicroRNAsAnimalsCell Line, TumorCell ProliferationHumansRNA, CircularSmoothened ReceptorMicroRNAsMIRN326 microRNA, humanRNA, CircularSmoothened ReceptorSMO protein, human

Identifiers

PMID36718820
OpenAlexW4318670422

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.